PROTAC CDK9 degrader-11
PROTAC CDK9 degrader-11 (Compound C3) is an orally active PROTAC degrader for CDK9 with DC50 of 1.09 nM. PROTAC CDK9 degrader-11 exhibits cytotoxicity in multi small cell lung cancer cell with IC50 of nanomolar levels. PROTAC CDK9 degrader-11 arrests cell cycle at G0/G1 phase, inhibits the cell invasion in DMS114 and DMS53 cell. PROTAC CDK9 degrader-11 exhibits antitumor efficacy in NCI-H446 xenograft mouse models[1]. (Pink: ligand for target protein CDK9 ligand 3 (HY-170979) ; Black: linker; Blue: ligand for E3 ligase Cereblon E3 ligase Ligand 56 (HY-W247437) )
Product Specifications
CAS Number
[3039540-19-4]
UNSPSC
12352005
Target
CDK; PROTACs
Related Pathways
Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(NC1=CNN=C1C(NC2CCN(CC2)C(CN3CCC(CC3)CN4CCN(CC4)C5=CC(NC6C(NC(CC6)=O)=O)=CC=C5)=O)=O)C7=C(C=CC=C7Cl)Cl
Molecular Formula
C39H48Cl2N10O5
Molecular Weight
807.77
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
UBQLN2, CT (Ubiquilin 2, Protein Linking IAP with Cytoskeleton-2, PLIC-2, hPLIC-2, Ubiquitin-like Product Chap1/Dsk2, DSK2 Homolog, Chap1, N4BP4, PLIC2, HRIHFB2157) (APC)
UBQLN2, CT (Ubiquilin 2, Protein Linking IAP with Cytoskeleton-2, PLIC-2, hPLIC-2, Ubiquitin-like Product Chap1/Dsk2, DSK2 Homolog, Chap1, N4BP4, PLIC2, HRIHFB2157) (APC)
